FDA approves Roxro's Sprix

FDA approved an NDA from Roxro Pharma Inc. (Menlo Park, Calif.) for Sprix ketorolac tromethamine nasal spray for short-term management of acute moderate to severe pain. Roxro said it is in negotiation...